A fly is going about its day, buzzing here, buzzing there—but then, it starts behaving weirdly. Its movements become sluggish ...

REC-3964 is the first novel small molecule developed through Recursion’s Operating System, and selectively inhibits the glucosyltransferase activity of toxin B produced by C. diff in the ...

SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. RXRX) on Wednesday reported a loss of $95.8 ... of action that binds and blocks catalytic activity of the toxin's innate glucosyltransferase in ...

The ability of bacteria to control the biophysical properties of their membrane phospholipids allows them to thrive in a wide range of physical environments. Fatty acid biosynthesis is an energy ...